Clinical Trial: A Study in Healthy Men to Compare the Amount of Vicadrostat and Empagliflozin in the Blood When Taken Separately and Together

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07035457) titled 'A Study in Healthy Men to Compare the Amount of Vicadrostat and Empagliflozin in the Blood When Taken Separately and Together' on June 17.

Brief Summary: The main objective of this trial is to investigate the relative bioavailability of vicadrostat and empagliflozin when administered in combination or individually.

Study Start Date: July 02

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Vicadrostat

Vicadrostat

DRUG: Jardiance(R)

Jardiance(R)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Boehringer Ingelheim

Disclaimer: Curated by HT Syndication....